M. Breuling
YOU?
Author Swipe
View article: Therapeutic Drug Monitoring of Elexacaftor, Tezacaftor, and Ivacaftor in Adult People with Cystic Fibrosis
Therapeutic Drug Monitoring of Elexacaftor, Tezacaftor, and Ivacaftor in Adult People with Cystic Fibrosis Open
Background/Objectives: Elexacaftor, tezacaftor, and ivacaftor (ETI) have significantly improved lung function in people with cystic fibrosis (pwCF). Despite exceptional improvements in most cases, treatment-related inter-subject variabilit…
View article: Butyrate- and Beta-Hydroxybutyrate-Mediated Effects of Interventions with Pro- and Prebiotics, Fasting, and Caloric Restrictions on Depression: A Systematic Review and Meta-Analysis
Butyrate- and Beta-Hydroxybutyrate-Mediated Effects of Interventions with Pro- and Prebiotics, Fasting, and Caloric Restrictions on Depression: A Systematic Review and Meta-Analysis Open
To examine the butyrate- and beta-hydroxybutyrate (BHB)-modulated effects of pre- and probiotic interventions, fasting, and caloric restriction interventions, a systematic literature review was carried out with a subsequent meta-analysis. …
View article: P059 Therapeutic drug monitoring of elexacaftor/tezacaftor/ivacaftor over 1 year in adult patients with cystic fibrosis
P059 Therapeutic drug monitoring of elexacaftor/tezacaftor/ivacaftor over 1 year in adult patients with cystic fibrosis Open
View article: 53 Pregnancies in women with cystic fibrosis with or without intake of elexacaftor/tezacaftor/ivacaftor
53 Pregnancies in women with cystic fibrosis with or without intake of elexacaftor/tezacaftor/ivacaftor Open